Researchers found that the vaccine, named ELI-002 2P, could trigger lasting immune responses and may help prevent or delay ...

Researchers recently discovered that an experimental cancer vaccine offers "a promising approach" to preventing cancers from ...

Zev A. Wainberg, MD, discussed the significance of the AMPLIFY-201 trial, next steps for this vaccine platform, and the signs ...

In a phase 1 study, ELI-002 2P improved relapse-free survival in pancreatic and colorectal cancer, with stronger benefit in ...

A new vaccine has shown encouraging early results in patients with pancreatic and colorectal cancer, according to a clinical trial led by the Jonsson Comprehensive Cancer Center at the University of ...

The vaccine would train the immune system to fight cancer-causing mutations, according to new research from UCLA Health.

For three colorectal cancer patients and three pancreatic cancer patients, the vaccine appeared to remove all disease ...

Phase 1 trial of a pancreatic cancer vaccine targeting mutant KRAS shows strong immune responses, extended survival, and ...

DENVER — Early data for a new vaccine for pancreatic cancer is generating some hope among patients, researchers and doctors.

A new study reveals promising results for a vaccine targeting colorectal and pancreatic cancers. Researchers from the ...